2.86
price up icon4.76%   0.13
after-market Dopo l'orario di chiusura: 2.73 -0.13 -4.55%
loading
Precedente Chiudi:
$2.73
Aprire:
$2.73
Volume 24 ore:
28,222
Relative Volume:
0.02
Capitalizzazione di mercato:
$4.42M
Reddito:
-
Utile/perdita netta:
$-2.66M
Rapporto P/E:
-0.9531
EPS:
-3.0006
Flusso di cassa netto:
$-2.83M
1 W Prestazione:
+3.25%
1M Prestazione:
+49.35%
6M Prestazione:
-9.05%
1 anno Prestazione:
-43.93%
Intervallo 1D:
Value
$2.7268
$2.86
Intervallo di 1 settimana:
Value
$2.6001
$3.21
Portata 52W:
Value
$1.725
$7.05

Xortx Therapeutics Inc Stock (XRTX) Company Profile

Name
Nome
Xortx Therapeutics Inc
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
3
Name
Cinguettio
Name
Prossima data di guadagno
2026-05-21
Name
Ultimi documenti SEC
Name
XRTX's Discussions on Twitter

Compare XRTX vs VRTX, REGN, ARGX, ALNY, ONC

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
XRTX icon
XRTX
Xortx Therapeutics Inc
2.86 4.29M 0 -2.66M -2.83M -3.0006
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
427.38 109.41B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
707.06 76.72B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
781.72 48.20B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
309.49 40.31B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
295.27 33.13B 5.36B 287.73M 924.18M 2.5229

Xortx Therapeutics Inc Borsa (XRTX) Ultime notizie

pulisher
Apr 26, 2026

XORTX shareholders approve up-to-5-for-1 share consolidation to meet Nasdaq rules - MSN

Apr 26, 2026
pulisher
Apr 23, 2026

XORTX Therapeutics (NASDAQ: XRTX) registers up to 2.2M shares; $4.7M estimated proceeds - Stock Titan

Apr 23, 2026
pulisher
Apr 23, 2026

XORTX Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filingmoomoo - Moomoo

Apr 23, 2026
pulisher
Apr 22, 2026

XORTX Regains Nasdaq Listing Compliance After Reverse Stock Split - The Globe and Mail

Apr 22, 2026
pulisher
Apr 22, 2026

XORTX Therapeutics (NASDAQ: XRTX) files F-1: 2.2M shares, pre-funded warrants - Stock Titan

Apr 22, 2026
pulisher
Apr 22, 2026

XRTX SEC FilingsXortx Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 22, 2026
pulisher
Apr 21, 2026

XRTX Stock Jumps As VB4-P5 Kidney Deal Expands Pipeline - StocksToTrade

Apr 21, 2026
pulisher
Apr 21, 2026

XRTX Stock Jumps As Kidney Pipeline Expands With VB4-P5 Deal - StocksToTrade

Apr 21, 2026
pulisher
Apr 21, 2026

XORTX Therapeutics jumps as it confirms Nasdaq bid-price compliance after reverse split - Quiver Quantitative

Apr 21, 2026
pulisher
Apr 21, 2026

XORTX (NASDAQ: XRTX) cures Nasdaq minimum bid deficiency - Stock Titan

Apr 21, 2026
pulisher
Apr 21, 2026

XRTX Jumps As New Kidney Fibrosis Deal Expands Pipeline - timothysykes.com

Apr 21, 2026
pulisher
Apr 21, 2026

XORTX Therapeutics Says Met Nasdaq Continued Listing Requirements - marketscreener.com

Apr 21, 2026
pulisher
Apr 21, 2026

XORTX Meets Nasdaq Continued Listing Requirements - GlobeNewswire

Apr 21, 2026
pulisher
Apr 21, 2026

Promising Penny Stocks To Add to Your WatchlistApril 21st - MarketBeat

Apr 21, 2026
pulisher
Apr 20, 2026

After 1-for-5 reverse split, XORTX clears Nasdaq $1 bid rule - Stock Titan

Apr 20, 2026
pulisher
Apr 20, 2026

XORTX Therapeutics (XRTX) Stock: Insider Signals (Smart Money Outflows) 2026-04-20Real Trader Network - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 20, 2026
pulisher
Apr 16, 2026

XORTX (NASDAQ: XRTX) closes $3M VB4-P5 kidney anti-fibrotic deal - Stock Titan

Apr 16, 2026
pulisher
Apr 14, 2026

Discontinued operations of XORTX Therapeutics, Inc. – DUS:ANU - TradingView — Track All Markets

Apr 14, 2026
pulisher
Apr 14, 2026

Long term debt to total equity ratio of XORTX Therapeutics, Inc. – DUS:ANU - TradingView

Apr 14, 2026
pulisher
Apr 14, 2026

EBITDA per share of XORTX Therapeutics, Inc. – DUS:ANU - TradingView

Apr 14, 2026
pulisher
Apr 13, 2026

Xortx announces closing of acquisition of Vectus kidney anti-fibrotic asset - marketscreener.com

Apr 13, 2026
pulisher
Apr 13, 2026

XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset - The Manila Times

Apr 13, 2026
pulisher
Apr 13, 2026

Hedge Fund Moves: What is the target price for XORTX Therapeutics Inc stockProduct Launch & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 10, 2026

Is XORTX Therapeutics Inc vulnerable to short sellers2026 Price Action Summary & Real-Time Volume Analysis - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 09, 2026

XORTX Therapeutics : Investor Presentation - marketscreener.com

Apr 09, 2026
pulisher
Apr 09, 2026

Aug Update: Can XORTX Therapeutics Inc continue delivering strong returnsWeekly Trade Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 09, 2026

Bond Watch: Is XORTX Therapeutics Inc a speculative investmentWall Street Watch & Low Risk Entry Point Tips - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 09, 2026

Long term debt to total equity ratio of XORTX Therapeutics, Inc. – TRADEGATE:ANU - TradingView — Track All Markets

Apr 09, 2026
pulisher
Apr 08, 2026

XORTX Therapeutics Inc. R (ANUA.MU) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Apr 08, 2026
pulisher
Apr 08, 2026

XORTX Therapeutics, Inc. Revenue Breakdown – LS:A427MJ - TradingView

Apr 08, 2026
pulisher
Apr 08, 2026

Gross margin % of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets

Apr 08, 2026
pulisher
Apr 08, 2026

Tangible book value per share of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView

Apr 08, 2026
pulisher
Apr 08, 2026

XORTX Therapeutics, Inc. Balance Sheet – LS:A427MJ - TradingView — Track All Markets

Apr 08, 2026
pulisher
Apr 08, 2026

Operating cash flow per share of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets

Apr 08, 2026
pulisher
Apr 08, 2026

XORTX Therapeutics, Inc. Dividends – LS:A427MJ - TradingView — Track All Markets

Apr 08, 2026
pulisher
Apr 08, 2026

Discontinued operations of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets

Apr 08, 2026
pulisher
Apr 08, 2026

Operating margin % of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets

Apr 08, 2026
pulisher
Apr 08, 2026

Discontinued operations of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets

Apr 08, 2026
pulisher
Apr 08, 2026

EBITDA margin % of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets

Apr 08, 2026
pulisher
Apr 08, 2026

Gross profit of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets

Apr 08, 2026
pulisher
Apr 08, 2026

Cash from investing activities of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets

Apr 08, 2026
pulisher
Apr 08, 2026

Long term debt to total equity ratio of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets

Apr 08, 2026
pulisher
Apr 08, 2026

Preferred dividends of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets

Apr 08, 2026
pulisher
Apr 08, 2026

XORTX Therapeutics, Inc. Cash Flow – LSX:A427MJ - TradingView — Track All Markets

Apr 08, 2026
pulisher
Apr 08, 2026

XORTX Therapeutics, Inc. Cash Flow – LS:A427MJ - TradingView — Track All Markets

Apr 08, 2026
pulisher
Apr 08, 2026

Net income before discontinued operations of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets

Apr 08, 2026
pulisher
Apr 08, 2026

Diluted earnings per share (diluted EPS) of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets

Apr 08, 2026
pulisher
Apr 08, 2026

Long term debt to total assets ratio of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView

Apr 08, 2026
pulisher
Apr 08, 2026

Non-operating income (total) of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets

Apr 08, 2026
pulisher
Apr 08, 2026

EBIT per share of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets

Apr 08, 2026
pulisher
Apr 08, 2026

EBITDA margin % of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets

Apr 08, 2026

Xortx Therapeutics Inc Azioni (XRTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$28.53
price up icon 3.67%
$50.09
price up icon 1.21%
$103.45
price up icon 1.85%
$136.33
price up icon 0.96%
$144.12
price up icon 2.54%
ONC ONC
$295.27
price up icon 1.54%
Capitalizzazione:     |  Volume (24 ore):